vs

Side-by-side financial comparison of BILL Holdings, Inc. (BILL) and Guardian Pharmacy Services, Inc. (GRDN). Click either name above to swap in a different company.

BILL Holdings, Inc. is the larger business by last-quarter revenue ($414.7M vs $397.6M, roughly 1.0× Guardian Pharmacy Services, Inc.). Guardian Pharmacy Services, Inc. runs the higher net margin — 5.3% vs -0.6%, a 5.9% gap on every dollar of revenue.

BILL Holdings, Inc. is an American company based in San Jose, California, that provides automated, cloud-based software for financial operations for small businesses in the United States. A white-labeled, end-to-end payments automation platform, Bill.com Connect is offered to financial institutions as part of their single sign-on online business banking ecosystem.

CVS Pharmacy Inc. is an American retail corporation. A subsidiary of CVS Health, it is headquartered in Woonsocket, Rhode Island. Originally named the Consumer Value Stores, it was founded in Lowell, Massachusetts, in 1963.

BILL vs GRDN — Head-to-Head

Bigger by revenue
BILL
BILL
1.0× larger
BILL
$414.7M
$397.6M
GRDN
Higher net margin
GRDN
GRDN
5.9% more per $
GRDN
5.3%
-0.6%
BILL

Income Statement — Q2 FY2026 vs Q4 FY2025

Metric
BILL
BILL
GRDN
GRDN
Revenue
$414.7M
$397.6M
Net Profit
$-2.6M
$20.9M
Gross Margin
79.8%
21.5%
Operating Margin
-4.4%
7.7%
Net Margin
-0.6%
5.3%
Revenue YoY
14.4%
Net Profit YoY
-107.7%
EPS (diluted)
$-0.03

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BILL
BILL
GRDN
GRDN
Q4 25
$414.7M
$397.6M
Q3 25
$395.7M
$377.4M
Q2 25
$383.3M
$344.3M
Q1 25
$358.2M
$329.3M
Q4 24
$362.6M
Q3 24
$358.4M
$314.4M
Q2 24
$343.7M
Q1 24
$323.0M
Net Profit
BILL
BILL
GRDN
GRDN
Q4 25
$-2.6M
$20.9M
Q3 25
$-3.0M
$9.8M
Q2 25
$-7.1M
$9.0M
Q1 25
$-11.6M
$9.4M
Q4 24
$33.5M
Q3 24
$8.9M
$-122.0M
Q2 24
$7.6M
Q1 24
$31.8M
Gross Margin
BILL
BILL
GRDN
GRDN
Q4 25
79.8%
21.5%
Q3 25
80.5%
19.8%
Q2 25
80.8%
19.8%
Q1 25
81.2%
19.5%
Q4 24
81.6%
Q3 24
82.0%
19.4%
Q2 24
81.0%
Q1 24
83.0%
Operating Margin
BILL
BILL
GRDN
GRDN
Q4 25
-4.4%
7.7%
Q3 25
-5.2%
4.3%
Q2 25
-5.8%
3.7%
Q1 25
-8.1%
3.9%
Q4 24
-6.0%
Q3 24
-2.1%
-33.3%
Q2 24
-6.5%
Q1 24
-8.6%
Net Margin
BILL
BILL
GRDN
GRDN
Q4 25
-0.6%
5.3%
Q3 25
-0.7%
2.6%
Q2 25
-1.8%
2.6%
Q1 25
-3.2%
2.9%
Q4 24
9.3%
Q3 24
2.5%
-38.8%
Q2 24
2.2%
Q1 24
9.8%
EPS (diluted)
BILL
BILL
GRDN
GRDN
Q4 25
$-0.03
Q3 25
$-0.03
Q2 25
$0.02
Q1 25
$-0.11
Q4 24
$-0.06
Q3 24
$0.08
Q2 24
$0.37
Q1 24
$0.00

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BILL
BILL
GRDN
GRDN
Cash + ST InvestmentsLiquidity on hand
$1.1B
$65.6M
Total DebtLower is stronger
$1.8B
$0
Stockholders' EquityBook value
$3.8B
$217.9M
Total Assets
$10.1B
$412.7M
Debt / EquityLower = less leverage
0.48×
0.00×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BILL
BILL
GRDN
GRDN
Q4 25
$1.1B
$65.6M
Q3 25
$1.1B
$36.5M
Q2 25
$1.0B
$18.8M
Q1 25
$1.0B
$14.0M
Q4 24
$1.6B
Q3 24
$853.5M
$37.2M
Q2 24
$985.9M
Q1 24
$952.5M
Total Debt
BILL
BILL
GRDN
GRDN
Q4 25
$1.8B
$0
Q3 25
$1.9B
Q2 25
$1.7B
Q1 25
$1.7B
Q4 24
$1.7B
Q3 24
$914.8M
$34.3M
Q2 24
$914.0M
Q1 24
$1.1B
Stockholders' Equity
BILL
BILL
GRDN
GRDN
Q4 25
$3.8B
$217.9M
Q3 25
$3.9B
$195.5M
Q2 25
$3.9B
$179.7M
Q1 25
$3.9B
$163.2M
Q4 24
$3.8B
Q3 24
$4.0B
$133.9M
Q2 24
$4.1B
Q1 24
$4.1B
Total Assets
BILL
BILL
GRDN
GRDN
Q4 25
$10.1B
$412.7M
Q3 25
$10.2B
$390.0M
Q2 25
$10.1B
$356.3M
Q1 25
$9.6B
$334.0M
Q4 24
$9.7B
Q3 24
$9.0B
$348.0M
Q2 24
$9.2B
Q1 24
$9.1B
Debt / Equity
BILL
BILL
GRDN
GRDN
Q4 25
0.48×
0.00×
Q3 25
0.48×
Q2 25
0.44×
Q1 25
0.43×
Q4 24
0.44×
Q3 24
0.23×
0.26×
Q2 24
0.22×
Q1 24
0.28×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BILL
BILL
GRDN
GRDN
Operating Cash FlowLast quarter
$105.3M
$34.6M
Free Cash FlowOCF − Capex
$103.8M
FCF MarginFCF / Revenue
25.0%
Capex IntensityCapex / Revenue
0.4%
Cash ConversionOCF / Net Profit
1.65×
TTM Free Cash FlowTrailing 4 quarters
$378.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BILL
BILL
GRDN
GRDN
Q4 25
$105.3M
$34.6M
Q3 25
$96.9M
$28.2M
Q2 25
$83.8M
$19.9M
Q1 25
$99.5M
$17.6M
Q4 24
$78.7M
Q3 24
$88.6M
Q2 24
$78.6M
Q1 24
$66.8M
Free Cash Flow
BILL
BILL
GRDN
GRDN
Q4 25
$103.8M
Q3 25
$95.6M
$24.2M
Q2 25
$81.0M
Q1 25
$98.4M
Q4 24
$78.3M
Q3 24
$88.6M
Q2 24
$78.4M
Q1 24
$66.8M
FCF Margin
BILL
BILL
GRDN
GRDN
Q4 25
25.0%
Q3 25
24.1%
6.4%
Q2 25
21.1%
Q1 25
27.5%
Q4 24
21.6%
Q3 24
24.7%
Q2 24
22.8%
Q1 24
20.7%
Capex Intensity
BILL
BILL
GRDN
GRDN
Q4 25
0.4%
Q3 25
0.3%
1.1%
Q2 25
0.7%
Q1 25
0.3%
Q4 24
0.1%
Q3 24
0.0%
Q2 24
0.1%
Q1 24
0.0%
Cash Conversion
BILL
BILL
GRDN
GRDN
Q4 25
1.65×
Q3 25
2.87×
Q2 25
2.21×
Q1 25
1.86×
Q4 24
2.35×
Q3 24
9.94×
Q2 24
10.35×
Q1 24
2.10×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

BILL
BILL

Accounts Payable And Accounts Receivable Solutions$185.9M45%
Spend And Expense Interchange Revenue$166.5M40%
Interest On Funds Held For Customers$39.5M10%
Embedded And Other Solutions$22.8M5%

GRDN
GRDN

Segment breakdown not available.

Related Comparisons